Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Platt

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Pigment Cell Research|January 7, 1999
Melanoma x macrophage fusion hybrids acquire increased melanogenesis and metastatic potential: altered N-glycosylation as an underlying mechanismS A Sodi, A K Chakraborty, J T Platt, et al.
Plos One|July 13, 2022
Comparison of anterior nares CT values in asymptomatic and symptomatic individuals diagnosed with SARS-CoV-2 in a university screening programSamantha M Hall, Lena Landaverde, Christopher J Gill, et al.
Cancer Discovery|December 15, 2012
Genotype-selective combination therapies for melanoma identified by high-throughput drug screeningMatthew A Held, Casey G Langdon, James T Platt, et al.
Oncotarget|October 21, 2015
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cellsCasey G Langdon, Norbert Wiedemann, Matthew A Held, et al.
Cancer Cell|December 17, 2011
β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomasWilliam E Damsky, David P Curley, Manjula Santhanakrishnan, et al.
JAMA Network Open|February 25, 2022
Association of COVID-19 Quarantine Duration and Postquarantine Transmission Risk in 4 University CohortsAndrew Bo Liu, Dan Davidi, Hannah Emily Landsberg, et al.
Oncotarget|October 8, 2016
RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulationJianqi Yang, Lance T Platt, Biswanath Maity, et al.
Molecular Cancer Therapeutics|March 16, 2017
Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation InhibitorCasey G Langdon, James T Platt, Robert E Means, et al.
Cancer Cell|January 14, 2015
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formationWilliam Damsky, Goran Micevic, Katrina Meeth, et al.
Cancer Research|February 26, 2015
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic TargetsMarzia Scortegagna, Eric Lau, Tongwu Zhang, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Pigment Cell Research|January 7, 1999
Melanoma x macrophage fusion hybrids acquire increased melanogenesis and metastatic potential: altered N-glycosylation as an underlying mechanismS A Sodi, A K Chakraborty, J T Platt, et al.
Plos One|July 13, 2022
Comparison of anterior nares CT values in asymptomatic and symptomatic individuals diagnosed with SARS-CoV-2 in a university screening programSamantha M Hall, Lena Landaverde, Christopher J Gill, et al.
Cancer Discovery|December 15, 2012
Genotype-selective combination therapies for melanoma identified by high-throughput drug screeningMatthew A Held, Casey G Langdon, James T Platt, et al.
Oncotarget|October 21, 2015
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cellsCasey G Langdon, Norbert Wiedemann, Matthew A Held, et al.
Cancer Cell|December 17, 2011
β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomasWilliam E Damsky, David P Curley, Manjula Santhanakrishnan, et al.
JAMA Network Open|February 25, 2022
Association of COVID-19 Quarantine Duration and Postquarantine Transmission Risk in 4 University CohortsAndrew Bo Liu, Dan Davidi, Hannah Emily Landsberg, et al.
Oncotarget|October 8, 2016
RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulationJianqi Yang, Lance T Platt, Biswanath Maity, et al.
Molecular Cancer Therapeutics|March 16, 2017
Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation InhibitorCasey G Langdon, James T Platt, Robert E Means, et al.
Cancer Cell|January 14, 2015
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formationWilliam Damsky, Goran Micevic, Katrina Meeth, et al.
Cancer Research|February 26, 2015
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic TargetsMarzia Scortegagna, Eric Lau, Tongwu Zhang, et al.
Pageof 14